A comparison of the sarcopenic effect of androgen receptor-axis-targeted agents vs. androgen depriva...
A comparison of the sarcopenic effect of androgen receptor-axis-targeted agents vs. androgen deprivation alone in patients with metastatic prostate cancer
About this item
Full title
Author / Creator
Publisher
Canada: Canadian Urological Association
Journal title
Language
English
Formats
Publication information
Publisher
Canada: Canadian Urological Association
Subjects
More information
Scope and Contents
Contents
Introduction: Androgen deprivation therapy (ADT) with androgen receptor axis-targeted (ARAT) therapy is the standard of care provided to patients with metastatic prostate cancer. While effective, it results in sequelae, such as loss of skeletal muscle mass. In this study, we compared the sarcopenic effects of abiraterone and enzalutamide, two ARATs...
Alternative Titles
Full title
A comparison of the sarcopenic effect of androgen receptor-axis-targeted agents vs. androgen deprivation alone in patients with metastatic prostate cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10426421
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10426421
Other Identifiers
ISSN
1911-6470
E-ISSN
1920-1214
DOI
10.5489/cuaj.8245
